Difficulty: Medium
Average Score: 65%
Practice
The following is a noncompetitive antagonist at the gastric parietal cell HÔéé receptor.
Correct answer
B
Rationale
The correct answer is B) Loxatidine. Loxatidine is a noncompetitive antagonist at the gastric parietal cell HÔéé receptor. As a noncompetitive antagonist, it binds irreversibly or with very high affinity to the receptor, resulting in a prolonged inhibitory effect on acid secretion from the parietal cells in the stomach.
A) Cimetidine is a competitive antagonist at the HÔéé receptor, meaning it competes with histamine for binding to the receptor but can be overcome by increasing the concentration of histamine.
C) Roxatidine and D) Ranitidine are both competitive antagonists at the HÔéé receptor, similar to Cimetidine. They compete with histamine but can be outcompeted by histamine itself.
Educational Context:
Understanding the mechanism of action of gastrointestinal drugs is crucial for healthcare professionals involved in managing conditions like peptic ulcers, gastroesophageal reflux disease (GERD), and other acid-related disorders. Knowing the differences between competitive and noncompetitive antagonists helps in selecting the most appropriate treatment for patients based on their condition and individual response to therapy.
A) Cimetidine is a competitive antagonist at the HÔéé receptor, meaning it competes with histamine for binding to the receptor but can be overcome by increasing the concentration of histamine.
C) Roxatidine and D) Ranitidine are both competitive antagonists at the HÔéé receptor, similar to Cimetidine. They compete with histamine but can be outcompeted by histamine itself.
Educational Context:
Understanding the mechanism of action of gastrointestinal drugs is crucial for healthcare professionals involved in managing conditions like peptic ulcers, gastroesophageal reflux disease (GERD), and other acid-related disorders. Knowing the differences between competitive and noncompetitive antagonists helps in selecting the most appropriate treatment for patients based on their condition and individual response to therapy.